Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives

This publication has 31 references indexed in Scilit:

• MeNZB™: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
  Vaccine, 2005
• Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes
  Vaccine, 2002
• Development of vaccines against meningococcal disease
  The Lancet, 2002
• Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine
  Vaccine, 2001
• Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6–8 October, 2000
  Vaccine, 2001
• Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations
  Vaccine, 2000
• The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
  The Journal of Infectious Diseases, 1999
• Advances in vaccine adjuvants
  Nature Biotechnology, 1999
• Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall Components
  Published by Elsevier ,1999
• Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
  Vaccine, 1996